ES2045092T3 - Un procedimiento de manufactura de un producto farmaceutico para tratamiento de cancer. - Google Patents

Un procedimiento de manufactura de un producto farmaceutico para tratamiento de cancer.

Info

Publication number
ES2045092T3
ES2045092T3 ES88202389T ES88202389T ES2045092T3 ES 2045092 T3 ES2045092 T3 ES 2045092T3 ES 88202389 T ES88202389 T ES 88202389T ES 88202389 T ES88202389 T ES 88202389T ES 2045092 T3 ES2045092 T3 ES 2045092T3
Authority
ES
Spain
Prior art keywords
met
pharmaceutical product
cancer treatment
manufacturing procedure
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88202389T
Other languages
English (en)
Spanish (es)
Inventor
Victor Johannes Nickolson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Application granted granted Critical
Publication of ES2045092T3 publication Critical patent/ES2045092T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
ES88202389T 1987-11-11 1988-10-27 Un procedimiento de manufactura de un producto farmaceutico para tratamiento de cancer. Expired - Lifetime ES2045092T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8702688 1987-11-11

Publications (1)

Publication Number Publication Date
ES2045092T3 true ES2045092T3 (es) 1994-01-16

Family

ID=19850895

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88202389T Expired - Lifetime ES2045092T3 (es) 1987-11-11 1988-10-27 Un procedimiento de manufactura de un producto farmaceutico para tratamiento de cancer.

Country Status (13)

Country Link
US (1) US5055449A (OSRAM)
EP (1) EP0316030B1 (OSRAM)
JP (1) JPH01163123A (OSRAM)
KR (1) KR890007752A (OSRAM)
AT (1) ATE70454T1 (OSRAM)
AU (1) AU612720B2 (OSRAM)
DE (1) DE3867039D1 (OSRAM)
DK (1) DK628388A (OSRAM)
ES (1) ES2045092T3 (OSRAM)
GR (1) GR3003930T3 (OSRAM)
IE (1) IE883296L (OSRAM)
NZ (1) NZ226915A (OSRAM)
ZA (1) ZA888335B (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4000154A1 (de) * 1990-01-04 1991-07-11 Symbiotec Gmbh Chemotherapeutisches mittel, insbesondere zur behandlung von krebserkrankungen
US5173521A (en) * 1990-06-19 1992-12-22 Mishima Paper Co., Ltd. Absorbent fibrous structure and producing method thereof
WO1993023072A1 (en) * 1992-05-13 1993-11-25 Akzo N.V. Aqueous hexapeptide compositions
US8110829B2 (en) 2007-05-31 2012-02-07 Lg Display Co., Ltd. Array substrate of liquid crystal display and method for fabricating the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL175174C (nl) * 1972-03-31 1984-10-01 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
OA06421A (fr) * 1980-06-10 1981-09-30 Omnium Chimique Sa Procédé de préparation de dérivés N-(vinblastinoyl-23) d'acides aminés et de peptides.

Also Published As

Publication number Publication date
IE883296L (en) 1989-05-11
ZA888335B (en) 1989-07-26
JPH01163123A (ja) 1989-06-27
DK628388D0 (da) 1988-11-10
KR890007752A (ko) 1989-07-05
EP0316030B1 (en) 1991-12-18
AU2490688A (en) 1989-05-11
GR3003930T3 (OSRAM) 1993-03-16
ATE70454T1 (de) 1992-01-15
NZ226915A (en) 1990-08-28
DE3867039D1 (de) 1992-01-30
DK628388A (da) 1989-05-12
AU612720B2 (en) 1991-07-18
US5055449A (en) 1991-10-08
EP0316030A1 (en) 1989-05-17

Similar Documents

Publication Publication Date Title
Wojtczak et al. Protection by pantothenic acid against apoptosis and cell damage by oxygen free radicals–the role of glutathione.
ES2093445T3 (es) Inyeccion y estuche de inyeccion que contiene omeprazol y sus analogos.
DE3170906D1 (en) Peptides, process for their preparation and medicaments or diagnostic agents containing them
AR018501A1 (es) Derivados de la dolastatina 15
Huang et al. Role of hippocampal nitric oxide in memory retention in rats
BR0008260A (pt) Medicamento para tratamento de hipertensão arterial
ECSP045373A (es) Sales de tolterodina
EP1192949A4 (en) PREVENTIVE OR THERAPEUTIC DRUGS FOR TREATING FIBROSIS AND CONTAINING CHYMASE INHIBITORS AS ACTIVE INGREDIENTS
DE122009000073I1 (de) Arzneimittel zur behandlung von viralen haut- und tumorerkrankungen
Venturini et al. Nitric oxide inhibits falcipain, the Plasmodium falciparum trophozoite cysteine protease
ES2124983T3 (es) Utilizacion de un antagonista de substancia p para el tratamiento de las manchas rojas cutaneas de origen neurogeno.
ES2045092T3 (es) Un procedimiento de manufactura de un producto farmaceutico para tratamiento de cancer.
CO4130200A1 (es) Inhibidores de proteasa del hiv utiles en el tratamiento del sida
Myers et al. Potentiation of human interferon production by superinduction
ATE3416T1 (de) Pharmakologisch aktive peptide und diese enthaltende arzneimittel.
ES2043351T3 (es) Preparado farmaceutico para el tratamiento de enfermedades hepaticas.
ATE205399T1 (de) Eine lagerstabile wässrige lösung zur infusion die einen thrombininhibitor enthält
CO5640064A2 (es) Citomodilacion de peptidos para tratar cistitis intersticial
WO2004028457A3 (en) PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF HIV gp41-DERIVED PEPTIDES, AND ITS USE IN THERAPY
YU60199A (sh) Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji
AR008245A1 (es) Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados
US5595734A (en) Compositions comprising ONCONASE (tm) and lovastatin
UA74170C2 (uk) Спосіб лікування порушень ерекції (варіанти), пептид для цього та фармацевтична композиція
ATE95171T1 (de) Cystein-derivate mit expectorans-wirkung.
RU2012145458A (ru) Соединения, используемые для лечения заболеваний, ассоциированных с экспрессией токсических транскриптов

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 316030

Country of ref document: ES